Call for Abstract
Scientific Program
5th International Conference on Preventive Oncology, will be organized around the theme “”
Preventive Oncology 2020 is comprised of 25 tracks and 162 sessions designed to offer comprehensive sessions that address current issues in Preventive Oncology 2020.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 1-1Lifestyle changes
- Track 1-2Diet & Cancer
- Track 1-3Vaccinations
- Track 1-4Natural Therapy
- Track 1-5Psychological & Social Aspects
- Track 2-1Stem Cell Research
- Track 2-2Cancer Stem Cells
- Track 2-3Stem Cells and Tumours
- Track 2-4Stem Cell Transplantation
- Track 2-5Bone Marrow Transplantation
- Track 2-6Cord Blood Stem Cells and Cancer
- Track 3-1Therapeutic Monoclonal Antibodies
- Track 3-2Small Molecule Drugs
- Track 3-3Tyrosine kinase inhibitors
- Track 3-4Hormone Therapies
- Track 3-5Implications of Targeted Therapy
- Track 3-6Targeted Cancer Therapy & Health Economics
- Track 4-1Gene Therapy
- Track 4-2Molecular Targeted Therapies
- Track 4-3Hormone Replacement Therapy
- Track 4-4Bone Marrow Transplantation
- Track 4-5Chemotherapy
- Track 4-6Radiation Therapy
- Track 4-7Biomarkers in cancer detection
- Track 4-8Immunotherapy
- Track 5-1Excisional biopsy
- Track 5-2Incisional biopsy
- Track 5-3Liquid biopsy
- Track 5-4Stereotactic guided biopsy
- Track 5-5Fine needle aspiration
- Track 6-1Sigmoidoscopy
- Track 6-2Colonoscopy
- Track 6-3Nuclear imaging
- Track 6-4Screening test
- Track 6-5Benefits of screening
- Track 6-6Angiogenesis Inhibitors
- Track 6-7Synthetic Lethality
- Track 6-8Risks of screening
- Track 6-9Molecular Diagnostics
- Track 7-1Oncogenes
- Track 7-2Proto-oncogenes
- Track 7-3Cancer predisposition
- Track 7-4Tumour Suppressors
- Track 7-5Genetic Cancer Syndromes
- Track 7-6Genetic Counselling & Testing
- Track 8-1Metastatic Symptoms
- Track 8-2Pathophysiology
- Track 8-3Organ Specific Targets
- Track 8-4Diagnosis & Management
- Track 8-5Multimodal Therapies
- Track 9-1Head & Neck Cancer
- Track 9-2Bone Cancer
- Track 9-3Skin Cancer
- Track 9-4Lung Cancer
- Track 9-5Blood Cancer
- Track 9-6Prostate Cancer
- Track 9-7Cervical Cancer
- Track 9-8Brain Cancer
- Track 9-9Pancreatic Cancer
- Track 9-10Thyroid Cancer
- Track 9-11Kidney Cancer
- Track 10-1Oncogenes
- Track 10-2Tumour Immunology
- Track 10-3Tumour Biology
- Track 10-4Tumour Progression
- Track 10-5Carcinogenesis & Mutagenesis
- Track 10-6Tumour Cell Interactions
- Track 10-7Cancer Cell Pathology
- Track 11-1Carcinogenesis
- Track 11-2Clinical Research
- Track 11-3Drug Discovery and Delivery
- Track 11-4Genetics, Genomics, and Proteomics
- Track 11-5Cell, Molecular, and Stem Cell Biology
- Track 11-6Chemotherapy
- Track 11-7Bone Marrow Transplantation
- Track 11-8Hormone Replacement Therapy
- Track 11-9Surgery and Laparoscopy
- Track 11-10Molecular Targeted Therapies
- Track 11-11Natural Therapy and Acupuncture
- Track 12-1
- Track 12-2
- Track 12-3
- Track 13-1Imaging Biomarker
- Track 13-2Clinical Biomarkers
- Track 13-3Genetic Biomarkers
- Track 13-4Predictive Cancer Biomarkers
- Track 13-5Molecular Biomarkers
- Track 13-6Cell Free Biomarkers
- Track 14-1Localized cancer
- Track 14-2Breast cancer
- Track 14-3Metastatic cancer
- Track 14-4Ovarian cancer
- Track 14-5Prostate cancer
- Track 15-1Trans anal Endoscopic Microsurgery
- Track 15-2Robotic surgery
- Track 15-3Reconstructive surgery
- Track 15-4Laparoscopic cancer surgery
- Track 15-5Cyto reductive surgery with HIPEC
- Track 15-6Sarcoma surgery
- Track 16-1 Cancer Specific Antigens
- Track 16-2Tumour Immunogenicity
- Track 16-3Antitumor Immune Response
- Track 16-4Tumour Elimination`
- Track 16-5Cancer Immuno surveillance
- Track 16-6Cancer Immunology and Chemotherapy
- Track 16-7 Cancer & Viruses
- Track 17-1 Tumour Targeting Strategies
- Track 17-2 Hormonal & Biological Agents
- Track 17-3 Cancer Drug Targets
- Track 17-4 Clinical Trials
- Track 17-5 Anticancer Therapeutics
- Track 17-6Preclinical Models for Drug Evaluation
- Track 17-7 Research and Analytical Methods
- Track 18-1 Gerson therapy
- Track 18-2Acupuncture
- Track 18-3Integrative Medicine
- Track 18-4Dietary Supplements and Herbal Remedies
- Track 18-5Biologic Treatments
- Track 18-6Meditation & Yoga
- Track 19-1Tumour cell proliferation
- Track 19-2Genomic Studies
- Track 19-3Cancer Genome Atlas(TCGA)
- Track 19-4Genomics Tools
- Track 19-5Metabolite Pathways
- Track 19-6Metabolic Technologies
- Track 19-7Data Interpretations
- Track 19-8Metabolomics as Biomarker
- Track 20-1Viral Mimicry of genes
- Track 20-2Principle investigator
- Track 20-3 Viral Therapy
- Track 20-4 Viral associated Cancers
- Track 21-1Nanoparticle packages
- Track 21-2Energy absorption and radiation
- Track 21-3Laser ablation
- Track 21-4Active pharmaceutical ingredients
- Track 21-5Passive Tumor Accumulation
- Track 21-6Active Tumor Targeting
- Track 22-1Nursing Education
- Track 22-2Nursing Management
- Track 22-3Nursing Law
- Track 22-4Clinical Nursing
- Track 22-5Critical Care
- Track 22-6Continuing Nursing Education
- Track 23-1Cancer Epigenetics
- Track 23-2Molecular Profiling Techniques
- Track 23-3New Biologics & Vaccines
- Track 23-4Chemical Proteomics
- Track 23-5Combination Strategies in Immuno oncology
- Track 23-6Novel Biomarker Discovery
- Track 24-1Alcohol and Tobacco
- Track 24-2Diet and Obesity
- Track 24-3Environmental pollutants
- Track 24-4 Radiation
- Track 24-5Magnetic Resonance Imaging
- Track 24-6Endoscopic Ultrasound
- Track 24-7Tumor Molecular Profiling
- Track 24-8 X-ray
- Track 24-9Nuclear Medicine Imaging
- Track 25-1Unexpected/Unusual Conditions
- Track 25-2Rare Surgical Condition of a cancer case
- Track 25-3Novel Surgical Procedure
- Track 25-4Adverse Effects